Shreepati Pharmaceuticals Private Limited

FDA inspection history in Dhar, India, 2023

1
Form 483

Every document, by year

  • Form 483

2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2023One Form 483, at Dhar, India.

Cited most

Across all Shreepati Pharmaceuticals Private Limited observations on file

The complete Shreepati Pharmaceuticals Private Limited file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2023-12-02483 Form 483$99

Investigators on these documents

Rose Jean-Mary (1)

FEI number 3005515162 · most recent document Dec 2, 2023

About Shreepati Pharmaceuticals Private Limited

How many FDA Form 483s has Shreepati Pharmaceuticals Private Limited received?

FDA Intel has 1 Form 483 on file for Shreepati Pharmaceuticals Private Limited; the most recent is dated Dec 2, 2023.

When was Shreepati Pharmaceuticals Private Limited last inspected by FDA?

The most recent FDA inspection document on file for Shreepati Pharmaceuticals Private Limited is a Form 483 dated Dec 2, 2023, for the site in Dhar, India.

What did FDA cite at Shreepati Pharmaceuticals Private Limited?

The regulations cited most in the observations on file for Shreepati Pharmaceuticals Private Limited are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.180 (General requirements), 1 time; 21 CFR 211.65 (Equipment construction), 1 time.